Clinical Trial Update: Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of dianicline versus placebo as an aid to smoking cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Dianicline (Dianicline)

Snippet

Sponsor: Sanofi | Conditions: Smoking | Phase 3 | Status: COMPLETED